Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Riddle

Showing results (211-220 of 221) with videos related to

Pageof 23
Sort By:
Ebiomedicine|April 16, 2021
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protectionKawsar R Talaat, Cristina Alaimo, Patricia Martin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2017
Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled TrialJoanna E Rimmer, Clayton Harro, David A Sack, et al.
The Lancet. Global Health|February 14, 2018
Global disability-adjusted life-year estimates of long-term health burden and undernutrition attributable to diarrhoeal diseases in children younger than 5 yearsChristopher Troeger, Danny V Colombara, Puja C Rao, et al.
The Journal of Clinical Investigation|July 2, 2019
Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severityPardeep Kumar, F Matthew Kuhlmann, Subhra Chakraborty, et al.
The Journal of Clinical Investigation|May 18, 2018
Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severityPardeep Kumar, F Matthew Kuhlmann, Subhra Chakraborty, et al.
Nature Microbiology|March 29, 2018
Campylobacter jejuni transcriptional and genetic adaptation during human infectionAlexander A Crofts, Frédéric M Poly, Cheryl P Ewing, et al.
Gastroenterology|January 12, 2023
Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative ColitisAlexandra E Livanos, Alexandra Dunn, Jeremy Fischer, et al.
JAMA Pediatrics|August 15, 2018
Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 YearsChristopher Troeger, Ibrahim A Khalil, Puja C Rao, et al.
The Lancet. Infectious Diseases|September 30, 2018
Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016Ibrahim A Khalil, Christopher Troeger, Brigette F Blacker, et al.
Gastroenterology|May 27, 2022
Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's DiseaseArthur Mortha, Romain Remark, Diane Marie Del Valle, et al.
Pageof 23

Showing results (211-220 of 221) with videos related to

Sort By:
Pageof 23
Ebiomedicine|April 16, 2021
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protectionKawsar R Talaat, Cristina Alaimo, Patricia Martin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2017
Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled TrialJoanna E Rimmer, Clayton Harro, David A Sack, et al.
The Lancet. Global Health|February 14, 2018
Global disability-adjusted life-year estimates of long-term health burden and undernutrition attributable to diarrhoeal diseases in children younger than 5 yearsChristopher Troeger, Danny V Colombara, Puja C Rao, et al.
The Journal of Clinical Investigation|July 2, 2019
Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severityPardeep Kumar, F Matthew Kuhlmann, Subhra Chakraborty, et al.
The Journal of Clinical Investigation|May 18, 2018
Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severityPardeep Kumar, F Matthew Kuhlmann, Subhra Chakraborty, et al.
Nature Microbiology|March 29, 2018
Campylobacter jejuni transcriptional and genetic adaptation during human infectionAlexander A Crofts, Frédéric M Poly, Cheryl P Ewing, et al.
Gastroenterology|January 12, 2023
Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative ColitisAlexandra E Livanos, Alexandra Dunn, Jeremy Fischer, et al.
JAMA Pediatrics|August 15, 2018
Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 YearsChristopher Troeger, Ibrahim A Khalil, Puja C Rao, et al.
The Lancet. Infectious Diseases|September 30, 2018
Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016Ibrahim A Khalil, Christopher Troeger, Brigette F Blacker, et al.
Gastroenterology|May 27, 2022
Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's DiseaseArthur Mortha, Romain Remark, Diane Marie Del Valle, et al.
Pageof 23